Asian Pacific Journal of Cancer Care (Dec 2020)

Intracranial Hemangiopericytoma – A Case Report

  • Gilson Gabriel Viana Veloso,
  • Raul de Almeida Dutra,
  • Letícia de Almeida Dutra,
  • Pedro Teixeira Meireles,
  • Douglas Reis Abdalla,
  • Luiz Carlos Furtado de Almeida Júnior

DOI
https://doi.org/10.31557/apjcc.2020.5.4.351-354
Journal volume & issue
Vol. 5, no. 4
pp. 351 – 354

Abstract

Read online

Hemangiopericytoma is a rare mesenchymal tumor, considered as a subtype of soft tissue sarcomas with an incidence of 3.77/10.000.000 cases. Intracranial hemangiopericytomas account for less than 1% of all primary tumors of the central nervous system. Due to the lack of data available regarding this disease, national and international research provides information derived from retrospective case series and phase I and phase II studies. This is a case report of a young adult diagnosed with intracranial hemangiopericytoma in 2012 with a history of multiple recurrences and therapeutic approaches, assisted in a public health center in southeastern Brazil. Among the treatment options given to the patient, there are surgery, radiotherapy, and systemic chemotherapy (including alkylating and anthracyclines agents). Systemic therapy usually is offered after multiple recurrences or in a metastatic setting; although it increases progression-free survival, there is not enough data on objective response rate and does not yield increased overall survival.

Keywords